Vaxart, Inc. Cash Flow Statement
VXRT|13 years of annual SEC 10-K data (FY2009-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
Vaxart, Inc. generated $8M in operating cash flow and $8M in free cash flow in FY2025. Free cash flow margin was 3.2% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.04 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $16.3M | -$66.9M | -$82.5M | -$18.0M | -$9.6M | -$25.4M | -$19.1M | -$11.0M | -$8.9M | -$19.2M | -$25.4M | $878.0K | -$18.7M |
| Depreciation & Amortization | $8.6M | $8.8M | $8.6M | $3.2M | $100.0K | $100.0K | $1.1M | $2.4M | $3.0M | $3.1M | $3.0M | $376.0K | $502.0K |
| Operating Cash Flow | $7.7M | -$44.8M | -$70.5M | -$14.5M | -$10.0M | -$14.1M | -$9.6M | -$3.3M | -$13.9M | -$15.9M | -$33.7M | $39.9M | $6.2M |
| Capital Expenditures | $145.0K | $554.0K | $1.9M | $707.0K | $117.0K | $200.0K | $100.0K | $100.0K | $1.0M | $1.3M | $700.0K | $154.0K | $4.0K |
| Free Cash Flow | $7.6M | -$45.3M | -$72.3M | -$15.3M | -$10.2M | -$14.3M | -$9.7M | -$3.4M | -$14.9M | -$17.2M | -$34.4M | $39.8M | $6.2M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | $400.0K | $700.0K | $42.8M | $7.9M |
| FCF Margin | 3.2% | -157.9% | -980.1% | -1015.0% | -174.0% | -153.8% | -39.4% | -5.0% | -44.4% | -84.3% | -275.2% | 113.6% | 59.2% |